Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CEL SCI CORPCVM · Entity 7495 | Director · Chief Executive Officer | September 30, 2026 | October 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CEL SCI CORP
Report date September 30, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 318,763 |
Reported balance
After 2026-09-30 transaction · row 1
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 2,621 · Balance 318,763 |
| Common StockSEC Table I · non-derivative | IndirectTrustee | 311,547 |
Reported balance
Holding disclosure · report date 2026-09-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 311,547 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 1, 2026 16:44 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 2,621 | $2.06 | $5,399.26 |
DisclosureSEC source: 0001236030-26-000009 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,763 Read SEC document |
| August 25, 2026 Filed Aug 26, 2026 12:32 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 100,000 | $1.38 | $138,000.00 |
DisclosureSEC source: 0001236030-26-000008 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,142 F1 · shares: On August 25, 2026, Mr. Kersten purchased 100,000 shares of restricted stock directly from the Company at the closing price on August 24, 2026, the most recent closing price available. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 13:19 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 300,000 | $0.01 Strike: $1.49 | $3,000.00 |
DisclosureSEC source: 0001236030-26-000007 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 452,380 Underlying: Common Stock · 300,000 shares Expires 2036-08-13 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 12:33 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 5,192 | $1.04 | $5,399.68 |
DisclosureSEC source: 0001236030-26-000006 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,142 Read SEC document |
| May 14, 2026 Filed May 18, 2026 12:03 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 300,000 | $1.20 | $360,000.00 |
DisclosureSEC source: 0001236030-26-000005 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Trustee Disclosed balance after: 311,547 F1 · shares: On May 14, 2026, the de Clara Trust, of which Mr. Kersten is a trustee, purchased 300,000 shares of restricted stock directly from the Company at the closing price on May 13, 2026, the most recent closing price available. Read SEC document |
| May 13, 2026 Filed May 14, 2026 12:56 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 100,000 | $1.19 | $119,000.00 |
DisclosureSEC source: 0001236030-26-000004 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,497 F1 · shares: On May 13, 2026, Mr. Kersten purchased 100,000 shares of restricted stock directly from the Company at the closing price on May 12, 2026, the most recent closing price available. Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 10:59 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,682 | $3.21 | $5,399.22 |
DisclosureSEC source: 0001236030-26-000003 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,497 Read SEC document |
| January 22, 2026 Filed Jan 26, 2026 13:23 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 38,023 | $5.26 | $200,000.98 |
DisclosureSEC source: 0001236030-26-000002 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,815 F1 · shares: On January 22, 2026, Mr. Kersten purchased 38,023 shares of restricted stock directly from the Company at the closing price on January 21, 2026, the most recent closing price available. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 14:23 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 998 | $5.26 | $5,249.48 |
DisclosureSEC source: 0001236030-26-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,792 Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 13:48 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 8,389 | $5.96 | $49,998.44 |
DisclosureSEC source: 0001236030-25-000019 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,794 F1 · shares: On December 4, 2025, Mr. Kersten purchased 8,389 shares of restricted stock directly from the Company at the closing price on December 3, 2025, the most recent closing price available. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 19:46 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 570 | $9.20 | $5,244.00 |
DisclosureSEC source: 0001236030-25-000016 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,405 Read SEC document |
| July 28, 2025 Filed Jul 29, 2025 20:55 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 25,000 | $0.01 Strike: $8.20 | $250.00 |
DisclosureSEC source: 0001236030-25-000009 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,157 Underlying: Common Stock · 25,000 shares Expires 2035-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 13:36 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 29,197 | $6.85 | $199,999.45 |
DisclosureSEC source: 0001236030-25-000007 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,835 F1 · shares: On July 25, 2025, Mr. Kersten purchased 29,197 shares of restricted stock directly from the Company at the closing price on July 24, 2025, the most recent closing price available. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 13:22 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 2,292 | $2.29 | $5,248.68 |
DisclosureSEC source: 0001236030-25-000004 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,638 Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 13:46 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 22,786 | $0.23 | $5,249.89 |
DisclosureSEC source: 0001236030-25-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,240,378 Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 19:25 UTC | CEL SCI CORP cvm · Entity 7495 | GrantCommon Stock | 12,940 | $0.40 | $5,176.00 |
DisclosureSEC source: 0001236215-25-000003 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,217,592 Read SEC document |
| September 30, 2024 Filed Oct 1, 2024 12:58 UTC | CEL SCI CORP cvm · Entity 7495 | GrantCommon Stock | 4,882 | $1.06 | $5,174.92 |
DisclosureSEC source: 0001236215-24-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,204,652 Read SEC document |
| June 28, 2024 Filed Jul 1, 2024 13:10 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 4,461 | $1.16 | $5,174.76 |
DisclosureSEC source: 0001236030-24-000016 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,199,770 Read SEC document |
| May 08, 2024 Filed May 9, 2024 13:19 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 30,000 | $1.39 | $41,700.00 |
DisclosureSEC source: 0001236030-24-000013 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,195,309 F1 · shares: On May 8, 2024, Mr. Kersten purchased 30,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 21:06 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 250,000 | $0.01 Strike: $1.50 | $2,500.00 |
DisclosureSEC source: 0001236030-24-000007 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,504,709 Underlying: Common Stock · 250,000 shares Expires 2034-04-18 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| March 29, 2024 Filed Apr 2, 2024 13:08 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 2,709 | $1.91 | $5,174.19 |
DisclosureSEC source: 0001236030-24-000004 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,165,309 Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 14:00 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,819 | $2.72 | $4,947.68 |
DisclosureSEC source: 0001236030-24-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,162,600 Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 14:37 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 3,960 | $1.25 | $4,950.00 |
DisclosureSEC source: 0001236030-23-000015 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,160,781 Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:28 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 250,000 | $0.01 Strike: $1.36 | $2,500.00 |
DisclosureSEC source: 0001236030-23-000007 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,258,309 Underlying: Common Stock · 250,000 shares Expires 2033-08-07 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 13:21 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 2,053 | $2.41 | $4,947.73 |
DisclosureSEC source: 0001236030-23-000004 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,156,821 Read SEC document |
| March 31, 2023 Filed Apr 6, 2023 20:15 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 2,133 | $2.32 | $4,948.56 |
DisclosureSEC source: 0001236030-23-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,154,768 Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 14:46 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,851 | $2.35 | $4,349.85 |
DisclosureSEC source: 0001236215-23-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,152,635 Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 11:15 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,407 | $3.09 | $4,347.63 |
DisclosureSEC source: 0001236215-22-000005 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150,784 Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 13:14 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 966 | $4.50 | $4,347.00 |
DisclosureSEC source: 0001236215-22-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,149,377 Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 21:13 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 250,000 | $0.01 Strike: $3.35 | $2,500.00 |
DisclosureSEC source: 0001236030-22-000009 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,030,109 Underlying: Common Stock · 250,000 shares Expires 2032-06-12 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| March 31, 2022 Filed Mar 31, 2022 20:49 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 1,106 | $3.93 | $4,346.58 |
DisclosureSEC source: 0001236030-22-000005 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,148,411 Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 15:04 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 612 | $7.10 | $4,345.20 |
DisclosureSEC source: 0001236030-22-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,147,305 Read SEC document |
| November 19, 2021 Filed Nov 29, 2021 14:17 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 50,000 | $0.01 Strike: $10.48 | $500.00 |
DisclosureSEC source: 0001236215-21-000011 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781,909 Underlying: Common Stock · 50,000 shares Expires 2031-11-18 F1 · derivative.exercise_date: Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.48 per share. The stock options vest 100% upon the approval of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia. None of the options will be exercisable before November 19, 2022. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 13:07 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 395 | $10.99 | $4,341.05 |
DisclosureSEC source: 0001236030-21-000003 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,146,693 Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 14:44 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 25,000 | $8.00 | $200,000.00 |
DisclosureSEC source: 0001646989-21-000006 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,146,298 F1 · balance_after: Includes 346,421 shares of common stock held by the de Clara Trust. On July 6, 2021, the Company sold 25,000 restricted shares of common stock to the de Clara Trust. Mr. Kersten is a beneficiary of the Trust. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 13:02 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 501 | $8.68 | $4,348.68 |
DisclosureSEC source: 0001282304-21-000005 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,121,298 Read SEC document |
| May 14, 2021 Filed May 17, 2021 21:10 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 592,000 | $0.01 Strike: $20.61 | $5,920.00 |
DisclosureSEC source: 0001236215-21-000003 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,731,909 Underlying: Common Stock · 592,000 shares Expires 2031-05-13 F1 · derivative.exercise_date: Each option entitles the holder to purchase one share of the Company's common stock at a price of $20.61 per share. The stock options vest 100% upon either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia, or (b) if the closing price of the Company's common stock exceeds $42.00 for one trading day. None of the options will be exercisable before May 13, 2022. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 14:03 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 285 | $15.21 | $4,334.85 |
DisclosureSEC source: 0001646989-21-000002 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120,797 Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 14:03 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 366 | $11.66 | $4,267.56 |
DisclosureSEC source: 0001236031-21-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120,512 Read SEC document |
| September 30, 2020 Filed Oct 1, 2020 13:30 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 335 | $12.75 | $4,271.25 |
DisclosureSEC source: 0001236031-20-000028 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,120,146 Read SEC document |
| June 30, 2020 Filed Jul 1, 2020 14:28 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 286 | $14.92 | $4,267.12 |
DisclosureSEC source: 0001236031-20-000024 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,811 Read SEC document |
| April 20, 2020 Filed Apr 20, 2020 20:41 UTC | CEL SCI CORP CVM · Entity 7495 | GrantOptions · Derivative | 592,000 | $0.01 Strike: $10.93 | $5,920.00 |
DisclosureSEC source: 0001236031-20-000016 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,142,309 Underlying: Common Stock · 592,000 shares Expires 2030-04-19 F1 · derivative.exercise_date: These stock options are performance based. Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.93 per share. The stock options vest upon the achievement of the following performance goals: i) 25% of the options will vest when the closing price of the Company's common stock exceeds $20.00 for ten consecutive trading days; ii) 50% of the options will vest when the closing price of the Company's common stock exceeds $25.00 for ten consecutive trading days; iii) 75% of the options will vest when the closing price of the Company's common stock exceeds $30.00 for ten consecutive trading days; and iv) 100% of the options will vest when either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia or (b) the closing price of the Company's common stock exceeds $40.00 for ten consecutive trading days. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 13:04 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 370 | $11.54 | $4,269.80 |
DisclosureSEC source: 0001236031-20-000012 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,525 Read SEC document |
| February 26, 2020 Filed Feb 27, 2020 12:33 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 4,617 | $10.83 | $50,002.11 |
DisclosureSEC source: 0001236031-20-000006 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,155 F1 · shares: On February 26, 2020, Mr. Kersten purchased $50,000 worth of restricted stock directly from the Company at the closing price on February 26, 2020, the most recent closing price available. Read SEC document |
| January 10, 2020 Filed Jan 13, 2020 13:10 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 6,631 | $7.54 | $49,997.74 |
DisclosureSEC source: 0001236031-20-000005 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114,538 F1 · shares: On January 10, 2020, Mr. Kersten purchased $50,000 worth of restricted stock directly from the Company at the closing price on January 9, 2020, the most recent closing price available. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 15:28 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 483 | $9.15 | $4,419.45 |
DisclosureSEC source: 0001236031-20-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,907 Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 10:32 UTC | CEL SCI CORP CVM · Entity 7495 | PurchaseCommon Stock | 3,725 | $6.71 | $24,994.75 |
DisclosureSEC source: 0001236031-19-000031 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,424 F1 · shares: On October 25, 2019, Mr. Kersten purchased $25,000 worth of restricted stock directly from the Company at the closing price on October 24, 2019, the most recent closing price available. Read SEC document |
| September 30, 2019 Filed Oct 1, 2019 20:34 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 461 | $8.94 | $4,121.34 |
DisclosureSEC source: 0001236031-19-000027 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,103,699 Read SEC document |
| September 04, 2019 Filed Sep 5, 2019 11:54 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 3,492 | $7.16 | $25,002.72 |
DisclosureSEC source: 0001236031-19-000023 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,102,746 Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 01:03 UTC | CEL SCI CORP CVM · Entity 7495 | GrantCommon Stock | 6,631 | $3.77 | $24,998.87 |
DisclosureSEC source: 0001236031-19-000021 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099,254 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.